SCHEMBL7035972

SCHEMBL7035972

C#Cc1c2ccccc2c(O)c2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.50
MEN1 O00255 2/20 0.50
MAPT P10636 2/20 0.50
KMT2A Q03164 2/20 0.50
ALDH1A1 P00352 1/20 0.50
GAA P10253 1/20 0.50
CACNA1B Q00975 1/20 0.50
APBA1 Q02410 1/20 0.50
THRB P10828 2/20 0.41
NPC1 O15118 1/20 0.41
POLB P06746 1/20 0.41
RECQL P46063 1/20 0.41
RAB9A P51151 1/20 0.41
BLM P54132 1/20 0.41
MCL1 Q07820 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CYP19A1 P11511 1/20 0.39
IDO1 P14902 1/20 0.38
PADI4 Q9UM07 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29870054 0.87 CYP19A1 (0.46) KDM4EMEN1MAPTKMT2AALDH1A1
SCHEMBL1478052 0.87 CYP19A1 (0.46) KDM4EMEN1MAPTKMT2AALDH1A1
SCHEMBL9929156 0.79 CYP19A1 (0.42) KDM4EMEN1MAPTKMT2AALDH1A1
SCHEMBL4193242 0.79 CYP19A1 (0.47) KDM4EMEN1MAPTKMT2AALDH1A1
SCHEMBL9861856 0.78 CYP19A1 (0.45) KDM4EMEN1MAPTKMT2AALDH1A1
SCHEMBL526630 0.78 IDO1 (0.56) KDM4EMEN1MAPTKMT2AALDH1A1
SCHEMBL16569927 0.75 CYP3A4 (0.40) KDM4EMEN1MAPTKMT2AALDH1A1
SCHEMBL27914766 0.75 KDM4E (0.77) KDM4EMEN1MAPTKMT2AALDH1A1
SCHEMBL7630201 0.75 CYP19A1 (0.39) KDM4EMEN1MAPTKMT2AALDH1A1
SCHEMBL7206760 0.74 IDO1 (0.53) KDM4EMEN1MAPTKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030065117-A1 Modified silicone compound, process of producing the same, and cured object obtained therefrom NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2003-04-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030065117-A1 Modified silicone compound, process of producing the same, and cured object obtained therefrom ORMDL3, SGMS1, HEATR1 KDM4E 2894/4885MEN1 1166/4885MAPT 3844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.